Markets

Freddie Mac priced its $284.2 million SLST Series 2025-1, comprising $262.9 million in government-backed senior certificates and $21.3 million in non-guaranteed subordinate notes, to enhance mortgage portfolio liquidity and share risk with private investors. Collateralized by 1,891 seasoned mortgages (≤150 days delinquent), the deal settles May 28, 2025. Part of its structured credit strategy, Freddie Mac has securitized $80.3 billion since 2011, aided by advisors BofA Securities and Wells Fargo. Senior tranches target low-risk investors, while subordinated notes offer higher returns. The transaction reflects ongoing efforts to optimize capital, reduce balance sheet risk, and comply with post-2008 reforms.

NVIDIA CEO Jensen Huang criticized U.S. AI chip export controls to China as a “failed strategy,” arguing they have spurred China’s semiconductor self-reliance while harming American firms. Speaking at COMPUTEX 2025, Huang noted Nvidia’s China market share dropped from 95% to 50% as local competitors emerged, with potential losses up to $15 billion from H20 chip restrictions. He warned Biden-era bans unintentionally accelerated China’s domestic R&D, with over half of global AI researchers now based there. The 2022 U.S. chipmaking equipment export ban drew backlash, with China condemning “unilateral bullying” harming global supply chains. Trump’s revocation of the “Intelligence Diffusion Rule” highlighted shifting market dynamics, underscoring policies that hinder innovation risk U.S. competitiveness.

Actress Zhu Yuanyuan and musician Zhao Yingjun, pivotal to China’s acclaimed film *Hi, Mom* (2020), have died of cancer, reigniting discussions on the drama’s themes of resilience and human connection amid illness. Zhu portrayed the mother of a terminally ill teen, while Zhao composed its evocative soundtrack. Directed by Han Yan, the film explores two cancer patients’ transformative bond, earning nominations at China’s Hundred Flowers and Huabiao Awards. Its enduring relevance highlights global cinema’s shift toward narratives that humanize medical adversity and amplify societal empathy. Critics praise their artistic legacy for mirroring real-world struggles with quiet courage.

Evofem Biosciences partners with UAE-based Pharma 1 to expand access to FDA-approved SOLOSEC® (secnidazole) for bacterial vaginosis and trichomoniasis in the Middle East. The agreement grants Pharma 1 exclusive commercialization rights, with plans to file for UAE regulatory approval by mid-2025. Evofem will supply SOLOSEC at cost-plus pricing, leveraging Pharma 1’s distribution network. Targeting a region with high BV prevalence (25%–41% in MENA), the single-dose therapy addresses compliance challenges linked to multi-day treatments. The deal aligns with Evofem’s global expansion strategy, building on prior collaborations for its contraceptive PHEXXI®, and aims to reduce health risks like HIV transmission and preterm births in underserved populations.

A 360 kg man from Inner Mongolia, once China’s heaviest person, lost nearly half his weight through bariatric surgery and lifestyle changes in four months, highlighting obesity management challenges. China’s obesity rate has tripled since 2004, with severe obesity (BMI ≥35) causing cascading health risks. Experts stress tiered interventions: behavioral changes, medications (e.g., GLP-1 agonists), and surgery, which requires lifelong monitoring. The global weight loss surgery market, valued at $2.4 billion in 2023, grows as obesity costs economies $2 trillion annually. While technology aids management, lasting success hinges on medical rigor and personal resolve, offering both caution and hope amid rising healthcare burdens.

In Q1 2025, WeRide reported RMB72.44 million ($10.1M) revenue and a 35% gross margin, with Robotaxi revenue surging 22.3% to RMB16.1M. The company expanded its Uber partnership, securing a $100M strategic investment and launching a $100M share buyback. Milestones included France’s first fully driverless permit, licenses across five countries, and an autonomous minibus pilot in Spain with Renault. Domestically, it tested Robovan W5 in Guangzhou’s smart city hub and launched a 24/7 autonomous ride-hailing network. The CFO emphasized scalable tech and global growth, as analysts highlighted WeRide’s dual regulatory-commercial strategy targeting a projected $2 trillion autonomous mobility market by 2040.

Tesla CEO Elon Musk acknowledged BYD’s growing competitiveness in EVs during a May 21 CNBC interview, contrasting his 2011 dismissal of the Chinese automaker. BYD outsold Tesla by 79,707 units in Q1 2025, capturing 15.4% of global BEV sales through vertical integration and aggressive pricing. While Musk emphasized focusing on Tesla’s mission over rivalries, analysts note BYD’s rise challenges Tesla’s dominance, potentially accelerating industry-wide decarbonization. The shift reflects evolving market dynamics as both companies vie for leadership in the electric transition. (98 words)

TreeHouse Foods, a leading North American private-label food manufacturer, will participate in two investor conferences in June 2025. On June 4, executives will present at the William Blair Growth Conference in Chicago, with a live webcast on their investor site. They will also attend the Jefferies Consumer Conference in Nantucket on June 17, conducting meetings to highlight growth strategies and market leadership in the $150 billion private-label sector. The company emphasizes innovation, affordability, and operational efficiency to meet consumer demand for value-driven products. Updates and replays will be available via their investor relations portal.

U.S. silicon carbide chipmaker Wolfspeed plans to file for Chapter 11 bankruptcy within weeks amid $5.3B debt struggles, regulatory filings show. After rejecting creditor proposals, the majority-backed bankruptcy aims to restructure obligations while maintaining operations. Shares plunged 60% post-announcement, exacerbating months of instability marked by leadership changes, 1,180 layoffs, and facility closures. Wolfspeed’s 2026 revenue projection of $850M trails analysts’ $958.7M forecast. The Durham-based firm, once a pioneer in EV/5G wafer tech, may attract acquisition bids despite debt hurdles. Its collapse risks disrupting silicon carbide supply chains and U.S. semiconductor self-sufficiency goals.

Gree Electric Chairman Dong Mingzhu and former protégé Meng Yutong will reunite in a May 23 livestream, their first joint appearance since 2022 rift rumors. The event, teased with “Long Time No See” on social media, follows Meng’s viral Weibo post—featuring private messages with Dong—that drew 15M+ views. In 2022, Gree trademarked both names across finance, tech, and advertising as Meng emerged as China’s top Gen-Z executive influencer. Analysts call the reunion a strategic fusion of leadership clout and youth marketing, while critics label it “calculated brand theater.” Public reactions range from skepticism to bewilderment.